DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Quixin (Levofloxacin Ophthalmic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

QUIXIN® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

AEROBIC GRAM-POSITIVE MICROORGANISMS AEROBIC GRAM-NEGATIVE MICROORGANISMS
Corynebacterium species 1 Acinetobacter lwoffii
Staphylococcus aureus Haemophilus influenzae
Staphylococcus epidermidis Serratia marcescens
Streptococcus pneumoniae
Streptococcus (Groups C/F)
Streptococcus (Group G)
Viridans group streptococci

1 Efficacy for this organism was studied in fewer than 10 infections.

DOSAGE AND ADMINISTRATION

Days 1 and 2

Instill one to two drops in the affected eye(s) every 2 hours while awake, up to 8 times per day.

Days 3 through 7

Instill one to two drops in the affected eye(s) every 4 hours while awake, up to 4 times per day.

HOW SUPPLIED

QUIXIN® (levofloxacin ophthalmic solution) 0.5% is supplied in a white, low density polyethylene bottle with a controlled dropper tip and a tan, high density polyethylene cap in the following size:

5 mL fill in 5 cc container - NDC 68669-135-05

Storage

Store at 15°– 25°C (59°–77°F)

Rx Only

Manufactured by:
Santen Oy, P. O. Box 33, FIN-33721 Tampere, Finland

Marketed by:
VISTAKON® Pharmaceuticals, LLC
Jacksonville, FL 32256 USA

Licensed from:
Daiichi Sankyo Co., Ltd., Tokyo, Japan

January 2011 Version

3220665/12

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017